Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 29.67% is in line with its 5-year average of 30.74%, near the high end of its 5-year range (1.03%–40.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.46% above its 12-month average of 22.92%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
29.67%
EBITDA MARGIN AVG TTM
22.92%
EBITDA MARGIN AVG 3Y
26.63%
EBITDA MARGIN AVG 5Y
30.74%
EBITDA MARGIN AVG 10Y
31.46%
EBITDA MARGIN AVG 15Y
35.54%
EBITDA MARGIN AVG 20Y
42.31%
CURRENT VS TTM AVG
+29.46%
CURRENT VS 3Y AVG
+11.39%
CURRENT VS 5Y AVG
-3.48%
CURRENT VS 10Y AVG
-5.70%
CURRENT VS 15Y AVG
-16.54%
CURRENT VS 20Y AVG
-29.89%
Bio-Techne Corporation
Market Cap
$11.31B
EBITDA Margin
29.67%
TTM Avg
22.92%
3Y Avg
26.63%
5Y Avg
30.74%
Market Cap
$10.76B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.44B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
Market Cap
$12.46B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$9.75B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$9.57B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.31B | 29.67% | 22.92% | 26.63% | 30.74% |
| DaVita Inc. (DVA)vs › | $11.65B | 19.98% | 20.97% | 19.78% | 20.10% |
| Molina Healthcare, Inc. (MOH)vs › | $10.76B | 2.15% | 3.41% | 4.20% | 4.49% |
| Universal Health Services, Inc. (UHS)vs › | $10.44B | 15.05% | 14.69% | 13.35% | 14.10% |
| Henry Schein, Inc. (HSIC)vs › | $10.34B | 8.11% | 8.11% | 8.28% | 8.19% |
| Align Technology, Inc. (ALGN)vs › | $12.46B | 19.75% | 19.29% | 19.87% | 21.06% |
| Insulet Corp. (PODD)vs › | $10.05B | 21.67% | 20.24% | 16.36% | 15.66% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.75B | 18.42% | 17.41% | 19.12% | 20.05% |
| Tempus AI, Inc. (TEM)vs › | $9.57B | -11.84% | -53.07% | -52.51% | -64.32% |
| Revvity, Inc. (RVTY)vs › | $13.15B | 23.07% | 26.75% | 30.05% | 32.80% |
Gross Margin
65.6%
EBITDA Margin
29.7%
Operating Margin
20.5%
Net Margin
15.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 29.67% |
| 2026-03-31 | 32.00% |
| 2025-12-31 | 26.76% |
| 2025-09-30 | 25.13% |
| 2025-06-30 | 1.03% |
| 2025-03-31 | 20.96% |
| 2024-12-31 | 25.08% |
| 2024-09-30 | 23.54% |
| 2024-06-30 | 24.14% |
| 2024-03-31 | 31.08% |
| 2023-12-31 | 24.14% |
| 2023-09-30 | 30.48% |
| 2023-06-30 | 40.31% |
| 2023-03-31 | 36.44% |
| 2022-12-31 | 34.83% |
| 2022-09-30 | 30.76% |
| 2022-06-30 | 36.93% |
| 2022-03-31 | 39.88% |
| 2021-12-31 | 32.48% |
| 2021-09-30 | 34.13% |
| 2021-06-30 | 36.00% |
| 2021-03-31 | 36.84% |
| 2020-12-31 | 32.05% |
| 2020-09-30 | 34.37% |
| 2020-06-30 | 34.29% |
| 2020-03-31 | 35.39% |
| 2019-12-31 | 31.12% |
| 2019-09-30 | 29.15% |
| 2019-06-30 | 32.96% |
| 2019-03-31 | 34.30% |
| 2018-12-31 | 30.65% |
| 2018-09-30 | 27.50% |
| 2018-06-30 | 33.32% |
| 2018-03-31 | 36.20% |
| 2017-12-31 | 25.79% |
| 2017-09-30 | 28.67% |
| 2017-06-30 | 35.91% |
| 2017-03-31 | 33.56% |
| 2016-12-31 | 24.09% |
| 2016-09-30 | 29.93% |
| 2016-06-30 | 37.60% |
| 2016-03-31 | 41.50% |
| 2015-12-31 | 38.55% |
| 2015-09-30 | 37.12% |
| 2015-06-30 | 40.20% |
| 2015-03-31 | 42.66% |
| 2014-12-31 | 39.73% |
| 2014-09-30 | 40.35% |
| 2014-06-30 | 47.73% |
| 2014-03-31 | 53.04% |
| 2013-12-31 | 48.32% |
| 2013-09-30 | 50.76% |
| 2013-06-30 | 53.93% |
| 2013-03-31 | 57.96% |
| 2012-12-31 | 53.38% |
| 2012-09-30 | 54.53% |
| 2012-06-30 | 56.33% |
| 2012-03-31 | 59.09% |
| 2011-12-31 | 54.73% |
| 2011-09-30 | 56.81% |
| 2011-06-30 | 58.13% |
| 2011-03-31 | 61.13% |
| 2010-12-31 | 55.42% |
| 2010-09-30 | 56.71% |
| 2010-06-30 | 61.44% |
| 2010-03-31 | 59.60% |
| 2009-12-31 | 58.93% |
| 2009-09-30 | 61.93% |
| 2009-06-30 | 59.18% |
| 2009-03-31 | 62.43% |
| 2008-12-31 | 55.94% |
| 2008-09-30 | 62.27% |
| 2008-06-30 | 60.21% |
| 2008-03-31 | 60.60% |
| 2007-12-31 | 55.67% |
| 2007-09-30 | 58.66% |
| 2007-06-30 | 58.73% |
| 2007-03-31 | 61.70% |
| 2006-12-31 | 55.68% |
| 2006-09-30 | 58.17% |
| 2006-06-30 | 58.58% |
| 2006-03-31 | 58.88% |
| 2005-12-31 | 54.17% |
| 2005-09-30 | 55.91% |
| 2005-06-30 | 59.60% |
| 2005-03-31 | 60.48% |
| 2004-12-31 | 55.90% |
| 2004-09-30 | 56.02% |
| 2004-06-30 | 56.00% |
| 2004-03-31 | 56.86% |
| 2003-12-31 | 52.19% |
| 2003-09-30 | 53.64% |
| 2003-06-30 | 52.36% |
| 2003-03-31 | 53.37% |
| 2002-12-31 | 48.47% |
| 2002-09-30 | 49.20% |
